Literature DB >> 20656416

Marginal misses after postoperative intensity-modulated radiotherapy for head and neck cancer.

Allen M Chen1, D Gregory Farwell, Quang Luu, Leon M Chen, Srinivasan Vijayakumar, James A Purdy.   

Abstract

PURPOSE: To describe the spatial distribution of local-regional recurrence (LRR) among patients treated postoperatively with intensity-modulated radiotherapy (IMRT) for head and neck cancer. METHODS AND MATERIALS: The medical records of 90 consecutive patients treated by gross total resection and postoperative IMRT for squamous cell carcinoma of the head and neck from January 2003 to July 2009 were reviewed. Sites of disease were the oral cavity (43 patients), oropharynx (20 patients), larynx (15 patients), and hypopharynx (12 patients). Fifty patients (56%) received concurrent chemotherapy.
RESULTS: Seventeen of 90 patients treated with postoperative IMRT experienced LRR, yielding a 2-year estimate of local regional control of 80%. Among the LRR patients, 11 patients were classified as in-field recurrences, occurring within the physician-designated clinical target volume, and 6 patients were categorized as marginal recurrences. There were no out-of-field geographical misses. Sites of marginal LRRs included the contralateral neck adjacent to the spared parotid gland (3 patients), the dermal/subcutaneous surface (2 patients), and the retropharyngeal/retrostyloid lymph node region (1 patient).
CONCLUSIONS: Although the incidence of geographical misses was relatively low, the possibility of this phenomenon should be considered in the design of target volumes among patients treated by postoperative IMRT for head and neck cancer.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20656416     DOI: 10.1016/j.ijrobp.2010.04.011

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  23 in total

1.  Adjuvance in refractory keloids using electron beams with a spoiler: Recent results.

Authors:  Antoni Vila Capel; Jorge Vilar Palop; Agustí Pedro Olivé; Alberto Sánchez-Reyes Fernández
Journal:  Rep Pract Oncol Radiother       Date:  2014-08-28

2.  Genital marginal failures after intensity-modulated radiation therapy (IMRT) in squamous cell anal cancer: no higher risk with IMRT when compared to 3DCRT.

Authors:  V Dell'Acqua; J Kobiela; F Kraja; M C Leonardi; A Surgo; M A Zerella; S Arculeo; C Fodor; R Ricotti; M G Zampino; S Ravenda; G Spinoglio; R Biffi; A Bazani; R Luraschi; S Vigorito; P Spychalski; R Orecchia; R Glynne-Jones; B A Jereczek-Fossa
Journal:  Med Oncol       Date:  2018-03-28       Impact factor: 3.064

3.  Intensity-modulated radiotherapy (IMRT) in the treatment of squamous cell anal canal cancer: acute and early-late toxicity, outcome, and efficacy.

Authors:  Veronica Dell'Acqua; Alessia Surgo; Simona Arculeo; Maria Alessia Zerella; Vincenzo Bagnardi; Samuele Frassoni; Maria Giulia Zampino; Paola Simona Ravenda; Maria Saveria Rotundo; Fatjona Kraja; Jarek Kobiela; Piotr Spychalski; Cristiana Fodor; Marianna Alessandra Gerardi; Federica Cattani; Alessia Bazani; Wanda Petz; Robert Glynne-Jones; Roberto Orecchia; Maria Cristina Leonardi; Barbara Alicja Jereczek-Fossa
Journal:  Int J Colorectal Dis       Date:  2020-02-08       Impact factor: 2.571

4.  Carotid sparing intensity-modulated radiation therapy achieves comparable locoregional control to conventional radiotherapy in T1-2N0 laryngeal carcinoma.

Authors:  Zachary S Zumsteg; Nadeem Riaz; Sana Jaffery; Man Hu; Daphna Gelblum; Ying Zhou; Borys Mychalczak; Michael J Zelefsky; Suzanne Wolden; Shyam Rao; Nancy Y Lee
Journal:  Oral Oncol       Date:  2015-05-07       Impact factor: 5.337

Review 5.  MRI-only treatment planning: benefits and challenges.

Authors:  Amir M Owrangi; Peter B Greer; Carri K Glide-Hurst
Journal:  Phys Med Biol       Date:  2018-02-26       Impact factor: 3.609

6.  Dose-dependent deterioration of swallowing function after induction chemotherapy and definitive chemoradiotherapy for laryngopharyngeal cancer.

Authors:  M Haderlein; S Semrau; O Ott; S Speer; C Bohr; R Fietkau
Journal:  Strahlenther Onkol       Date:  2014-02       Impact factor: 3.621

Review 7.  Intensity-modulated radiotherapy for head and neck surgeons.

Authors:  Stanley I Gutiontov; Edward J Shin; Benjamin Lok; Nancy Y Lee; Ruben Cabanillas
Journal:  Head Neck       Date:  2015-12-26       Impact factor: 3.147

8.  Whole-Field Sequential Intensity-Modulated Radiotherapy for Local-Regional Advanced Head-and-Neck Squamous Cell Carcinoma.

Authors:  Tamer Refaat; Mehee Choi; Tarita O Thomas; Ian Bacchus; Mark Agulnik; Harold J Pelzer; Ann L Mellott; Alfred W Rademaker; Dachao Liu; Vythialinga Sathiaseelan; Bharat B Mittal
Journal:  Am J Clin Oncol       Date:  2015-12       Impact factor: 2.339

9.  IMRT: preliminary results in a series of advanced head-and-neck cancer patients.

Authors:  Antonio Vila Capel; Jorge Vilar Palop; Agustín Pedro Olivé; Alberto Sanchez-Reyes Fernandez; Jordi Vayreda Ribera; Joan Carles Julià Sanahuja; Joaquim Pérez de Olaguer Agustín; Nuria Artola Codina; Luis Miguel Moya Cascant; Esther Rubio Calatayud; Gemma Carrera Domenech
Journal:  Clin Transl Oncol       Date:  2012-07-27       Impact factor: 3.405

Review 10.  Feasibility of intensity-modulated and image-guided radiotherapy for functional organ preservation in locally advanced laryngeal cancer.

Authors:  Nam P Nguyen; Alexander Chi; Michael Betz; Fabio Almeida; Paul Vos; Rick Davis; Benjamin Slane; Misty Ceizyk; Dave Abraham; Lexie Smith-Raymond; Michelle Stevie; Siyoung Jang; Steven Gelumbauskas; Vincent Vinh-Hung
Journal:  PLoS One       Date:  2012-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.